AutoCanada Inc
TSX:ACQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AutoCanada Inc
TSX:ACQ
|
CA |
|
Chemometec A/S
F:CHY
|
DK |
|
I
|
Iris Acquisition Corp
NASDAQ:IRAA
|
KY |
|
Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
|
US |
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
US |
|
Pacific Health Care Organization Inc
OTC:PFHO
|
US |
Wall Street
Price Targets
ACQ Price Targets Summary
AutoCanada Inc
According to Wall Street analysts, the average 1-year price target for
ACQ
is 24.9 CAD
with a low forecast of 20.2 CAD and a high forecast of 30.77 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ACQ's stock price target?
Price Target
24.9
CAD
According to Wall Street analysts, the average 1-year price target for
ACQ
is 24.9 CAD
with a low forecast of 20.2 CAD and a high forecast of 30.77 CAD.
What is AutoCanada Inc's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
AutoCanada Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
7%.
What is AutoCanada Inc's Operating Income forecast?
Projected CAGR
-28%
For the last 14 years the
compound annual growth rate for
AutoCanada Inc's operating income is
12%.
The projected
CAGR
for the next 3 years is
-28%.
What is AutoCanada Inc's Net Income forecast?
Projected CAGR
129%
For the last 14 years the
compound annual growth rate for
AutoCanada Inc's net income is
-6%.
The projected
CAGR
for the next 2 years is
129%.
